The then (July 6th, 2012 and earlier) and now charts;

At the time there were two distinct possibilities, the purple one where the stock would go down immediately or the green one where much of wave c of wave 2 still had to develop. QEs and other simulative measures no doubt contributed to the more time consuming second option. Today we got down to almost $30 ($12 below the level in June). This looks like a third wave that may have quite a bit more to go. Apparently an FDA report was released revealing that certain cables could easily fray and jeopardize the proper functioning of a heart device. Sounds innocent enough. Going lower!